Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer sells further shares in Sensodyne maker Haleon
Drug giant Pfizer sells $3.3 bln stake in Sensodyne-maker Haleon
Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil painkillers to 15% from 22.
Pfizer Raises $3.2 Billion by Selling Part of Haleon Stake
Pfizer Inc. plans to sell 540 million worth of shares in Haleon Plc, as it pares back its holding in the UK consumer health giant.
Pfizer sells further shares in Sensodyne maker Haleon for £2.4bn
Pfizer sells further shares in Sensodyne maker Haleon for £2.4bn - Haleon was formed in 2019 by the merger of the consumer healthcare businesses of GSK and US rival Pfizer, but was spun out and floated in 2022.
11h
Futura Medical due $5m milestone payment from Haleon
Futura Medical, the consumer healthcare company behind Eroxon, announced on Monday that a $5m milestone payment had been ...
Armed robbery in Revesby
3h
Haleon, Sydney Uni Propel Osteoarthritis Research
Haleon is teaming up with the University of Sydney to launch a five-year fellowship to research the efficacy of dietary supplements for ...
FiercePharma
6d
Pfizer gins up £2.4B after unloading hundreds of millions of Haleon shares
Following a similar move in March, Pfizer is offloading another tranche of Haleon shares. | Pfizer has sold 640 million ...
6d
Haleon Announces Leadership Transition in Canada: Rupa Bahri to Depart, Christine Jakovcic Appointed as New General Manager
Haleon, a global leader in consumer health, today announced the appointment of Christine Jakovcic as General Manager, Haleon ...
Drug Store News
3d
Dr. Reddy’s completes acquisition of Haleon’s Nicotinell
The acquired portfolio includes Nicotinell, also known as Nicabate in Australia, Thrive in Canada and Habitrol in New Zealand and Canada.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Pfizer
Sensodyne
GlaxoSmithKline
Feedback